| 2025-12-06 |
详情>>
内部人交易：
Wettig Thane股份减少259.00股
|
| 2025-11-10 |
详情>>
股本变动：
变动后总股本404.54万股
变动原因 ▼▲
- 原因：
- From June 30,2025 to September 30,2025
Shares issued from stock plans, net of payroll taxes paid
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益48.90美元,归母净利润1.98亿美元,同比去年增长401.51%
|
| 2025-11-10 |
财报披露：
美东时间 2025-11-10 盘后发布财报
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益-0.73美元,归母净利润-296.4万美元,同比去年增长93.89%
|
| 2025-06-17 |
复牌提示：
2025-06-16 19:50:00 停牌，复牌日期 2025-06-17 09:00:00
|
| 2025-06-12 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益0.05美元,归母净利润463.90万美元,同比去年增长114.09%
|
| 2025-04-25 |
股东大会：
将于2025-06-04召开股东大会
会议内容 ▼▲
- 1.To elect our Class II director nominee, Jeffrey L. Edwards, to our board of directors to hold office until the 2028 annual meeting of stockholders.
2.To approve a reverse stock split of the Company’s common stock, including granting our board of directors discretion to determine the final ratio and timing of the reverse stock split.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers.
4.To ratify the selection, by the Audit Committee of our board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025.
5.To conduct any other business properly brought before the meeting.
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益-0.48美元,归母净利润-4757.9万美元,同比去年增长83.26%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.66美元,归母净利润-6556.1万美元,同比去年增长71.25%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益-1.71美元,归母净利润-1.64亿美元,同比去年增长-21.02%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.49美元,归母净利润-4847.7万美元,同比去年增长70.51%
|
| 2024-05-06 |
详情>>
业绩披露：
2024年一季报每股收益-0.33美元,归母净利润-3293.3万美元,同比去年增长57.07%
|
| 2024-04-24 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.To elect our Class I director nominees, Thane Wettig, James A. Schoeneck, and Maykin Ho, Ph.D., to our board of directors to hold office until the 2027 annual meeting of stockholders.
2.To approve the FibroGen, Inc. 2024 Equity Incentive Plan.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers.
4.To ratify the selection, by the Audit Committee of our board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024.
5.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
6.To conduct any other business properly brought before the meeting.
|
| 2024-02-26 |
详情>>
业绩披露：
2023年年报每股收益-2.92美元,归母净利润-2.84亿美元,同比去年增长3.21%
|
| 2024-02-26 |
详情>>
业绩披露：
2022年年报每股收益-3.14美元,归母净利润-2.94亿美元,同比去年增长-1.25%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.35美元,归母净利润-2.28亿美元,同比去年增长-0.23%
|
| 2023-04-27 |
股东大会：
将于2023-06-07召开股东大会
会议内容 ▼▲
- 1.To elect our Class III director nominees, Enrique Conterno, Aoife Brennan, M.B., B.Ch., and Gerald Lema, to our board of directors to hold office until the 2026 annual meeting of stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection, by the Audit Committee of our board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023.
4.To conduct any other business properly brought before the meeting.
|
| 2022-04-29 |
股东大会：
将于2022-06-16召开股东大会
会议内容 ▼▲
- 1.To elect our Class II director nominees, Suzanne Blaug, Benjamin F. Cravatt, Ph.D., and Jeffrey L. Edwards, to our board of directors to hold office until the 2025 annual meeting of stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection, by the audit committee of our board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022.
4.To conduct any other business properly brought before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-13 |
股东大会：
将于2021-05-26召开股东大会
会议内容 ▼▲
- 1.To elect our Class I director nominees, James A. Schoeneck, Jeffrey W. Henderson, and Maykin Ho, Ph.D., to our board of directors to hold office until the 2024 annual meeting of stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection, by the audit committee of our board of directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2021.
4.To conduct any other business properly brought before the meeting.
|
| 2020-04-23 |
股东大会：
将于2020-06-04召开股东大会
会议内容 ▼▲
- 1.To elect our Class III director nominees, Enrique Conterno, Thomas F. Kearns Jr., Kalevi Kurkijrvi, Ph.D., and Gerald Lema, to our board of directors to hold office until the 2023 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection by the audit committee of our board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2020;
4.To conduct any other business properly brought before the meeting.
|
| 2019-04-23 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.To elect our Class II director nominees, Jeffrey L. Edwards, Rory B. Riggs, and Roberto Pedro Rosenkranz, Ph.D., M.B.A., to our board of directors to hold office until the 2022 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection by the audit committee of our board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2019.
4.To conduct any other business properly brought before the meeting.
|
| 2018-04-24 |
股东大会：
将于2018-06-05召开股东大会
会议内容 ▼▲
- 1.To elect our Class I director nominees, Thomas B. Neff, Jeffrey W. Henderson, and James A. Schoeneck, to our board of directors to hold office until the 2021 Annual Meeting of Stockholders.
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3.To ratify the selection by the audit committee of our board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2018.
4.To conduct any other business properly brought before the meeting.
|
| 2017-04-24 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1. To elect our Class III director nominees, Thomas F. Kearns Jr., Kalevi Kurkijarvi, Ph.D., and Toshinari Tamura, Ph.D., to our board of directors to hold office until the 2020 Annual Meeting of Stockholders.
2. To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
3. To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
4. To ratify the selection by the audit committee of our board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its year ending December 31, 2017.
5. To conduct any other business properly brought before the meeting.
|
| 2016-04-22 |
股东大会：
将于2016-06-08召开股东大会
会议内容 ▼▲
- 1.To elect our nominees, Jeffrey L. Edwards, Rory B. Riggs, Roberto P. Rosenkranz and Jorma Routti, to our board of directors to hold office until the 2019 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its year ending December 31, 2016.
3.To conduct any other business properly brought before the meeting.
|